Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$195M |
| 2 |
Comcast
CMCSA
|
+$164M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$157M |
| 4 |
AB InBev
BUD
|
+$151M |
| 5 |
FDC
First Data Corporation
FDC
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$414M |
| 2 |
AABA
Altaba Inc
AABA
|
+$290M |
| 3 |
Sherwin-Williams
SHW
|
+$229M |
| 4 |
Danaher
DHR
|
+$215M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Consumer Discretionary | 13.23% |
| 3 | Energy | 9.87% |
| 4 | Communication Services | 8.96% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Elevance Health
ELV
$86.9B
| $36.6M | 0.16% |
+162,700
| New | +$34.7M |
|
177
UnitedHealth
UNH
$350B
| $36.5M | 0.16% |
165,600
+125,600
| +314% | +$26.6M |
|
178
Martin Marietta Materials
MLM
$32.1B
| $36.3M | 0.16% |
+164,167
| New | +$34.4M |
|
179
Progressive
PGR
$127B
| $36.3M | 0.16% |
643,700
-158,972
| -20% | -$8.22M |
|
180
Citigroup
C
$221B
| $36M | 0.16% |
+484,002
| New | +$35.8M |
|
181
Hain Celestial
HAIN
$71.6M
| $35.9M | 0.15% |
846,320
-906,180
| -52% | -$35.9M |
|
|
SUM
182
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $35.6M | 0.15% |
1,152,369
+252,660
| +28% | +$7.6M |
|
183
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $35.6M | 0.15% |
+419,500
| New | +$35.1M |
|
184
Expedia Group
EXPE
$38.6B
| $35.1M | 0.15% |
+293,214
| New | +$38M |
|
185
TotalEnergies
TTE
$199B
| $34.7M | 0.15% |
57,549,663
+51,040,044
| +784% | +$30.5M |
|
186
PUT
Snap
SNAP
$8.86B
| $34.7M | 0.15% |
+2,372,400
| New | +$34.6M |
|
|
WFT
187
DELISTED
Weatherford International plc
WFT
| $34.6M | 0.15% |
8,293,300
+7,840,400
| +1,731% | +$28.9M |
|
188
CALL
Abbott
ABT
$202B
| $34.2M | 0.15% |
+600,000
| New | +$33.3M |
|
189
Gray Television
GTN
$509M
| $34.1M | 0.15% |
+2,037,356
| New | +$31.8M |
|
190
Plains GP Holdings
PAGP
$5.31B
| $34.1M | 0.15% |
1,552,500
-838,078
| -35% | -$17.6M |
|
191
MSC Industrial Direct
MSM
$6.69B
| $34.1M | 0.15% |
+352,356
| New | +$29.4M |
|
192
Charter Communications
CHTR
$17.9B
| $33.9M | 0.15% |
100,937
-136,615
| -58% | -$46.4M |
|
193
Honeywell
HON
$68.4B
| $33.4M | 0.14% |
241,274
+100,464
| +71% | +$13.5M |
|
|
EA
194
CALL
DELISTED
Electronic Arts
EA
| $33.4M | 0.14% |
+317,500
| New | +$35.3M |
|
|
TFCF
195
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $33.3M | 0.14% |
+975,923
| New | +$28.5M |
|
196
Sarepta Therapeutics
SRPT
$1.98B
| $32.3M | 0.14% |
579,757
-1,065,518
| -65% | -$56.4M |
|
197
Chemours
CC
$2.4B
| $32.2M | 0.14% |
643,958
+578,258
| +880% | +$30.3M |
|
198
Karyopharm Therapeutics
KPTI
$44.5M
| $32.2M | 0.14% |
+223,466
| New | +$35.9M |
|
199
AstraZeneca
AZN
$257B
| $32.1M | 0.14% |
462,600
-149,870
| -24% | -$10.1M |
|
200
United Airlines
UAL
$36.7B
| $31.9M | 0.14% |
473,166
-1,325
| -0.3% | -$82.6K |
|
Similar funds
Steven Cohen's Q4 2017 Portfolio in Review
As of Q4 2017, Steven Cohen held 1,233 positions worth $23.2B, up 3.4% from $22.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Steven Cohen's Q4 2017 filing shows 387 new, 243 increased, 233 reduced and 356 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 481,354 shares worth $181M. The largest sale was Time Warner Inc, an estimated $414M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- Steven Cohen's largest Q4 2017 buy was Regeneron Pharmaceuticals: 481,354 shares worth $181M.
- Steven Cohen added most to Comcast in Q4 2017, an estimated $164M increase.
- Steven Cohen's biggest Q4 2017 reduction was Time Warner Inc, cutting an estimated $414M.
- Steven Cohen fully exited Sherwin-Williams in Q4 2017, selling an estimated $229M.
- Steven Cohen's ten largest holdings make up 13% of its $23.2B portfolio in Q4 2017.
- Steven Cohen opened 387 new positions and closed 356 in Q4 2017.
- Steven Cohen's portfolio value rose 3.4% quarter-over-quarter to $23.2B.
Based on Point72 Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.